LPTH LightPath Technologies gains 10 percent in daily trading even as Q1 2026 earnings sharply miss analyst expectations Syndax Pharmaceuticals SNDX Stock Price Movement Behavior Q4 2025 Earnings Underperform RENX RenX Enterprises reports stable quarterly performance forecasts accelerated customer acquisition for upcoming fiscal periods